Cayman Islands | 6770 | 98-1802901 | ||||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) | ||||
David I. Gottlieb Paul J. Shim Cleary Gottlieb Steen & Hamilton LLP One Liberty Plaza New York, New York 10006 (212) 225-2000 | Gregg A. Noel Brian D. Paulson Skadden, Arps, Slate, Meagher & Flom LLP 525 University Avenue Palo Alto, California 94301 (650) 470-4500 | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | ||||||
Large accelerated filer | ☐ | Emerging growth company | ☒ | ||||||
PRELIMINARY PROSPECTUS | SUBJECT TO COMPLETION, DATED FEBRUARY 7, 2025 | ||
Per Unit | Total | |||||
Public offering price | $10.00 | $200,000,000 | ||||
Underwriting discounts and commissions(1) | $0.3125 | $6,250,000 | ||||
Proceeds, before expenses, to us | $9.6875 | $193,750,00 | ||||
(1) | Includes $250,000 (such amount to remain unchanged in the event the underwriter’s over-allotment option is exercised in full) payable to the underwriter upon the closing of this offering. Also includes $0.30 per unit on all units sold ($6,000,000 in the aggregate or up to $6,900,000 in the aggregate if the underwriter’s over-allotment option is exercised in full) payable to the underwriter for deferred underwriting commissions to be deposited into a trust account located in the United States and released to Santander US Capital Markets LLC or its own account only upon the completion of an initial business combination. Such deferred underwriting commissions will not be payable with respect to any shares redeemed in connection with an initial business combination, and may be paid at the sole and absolute discretion of our management team to any one or more FINRA members, which may or may not include the underwriter. See also “Underwriting” for a description of compensation and other items of value payable to the underwriter. |
As of December 31, 2024 | ||||||||||||||||||||||||
Redemption Deemed Offering Price of $9.09 per Unit | 25% of Maximum Redemption | 50% of Maximum Redemption | 75% of Maximum Redemption | Maximum Redemption | ||||||||||||||||||||
NTBV | NTBV | Difference between NTBV and Offering Price | NTBV | Difference between NTBV and Offering Price | NTBV | Difference between NTBV and Offering Price | NTBV | Difference between NTBV and Offering Price | ||||||||||||||||
Assuming Full Exercise of Over-Allotment Option | ||||||||||||||||||||||||
$6.97 | $6.36 | $2.73 | $5.38 | $3.71 | $3.61 | $5.48 | $(0.64) | $9.73 | ||||||||||||||||
Assuming No Exercise of Over-Allotment Option | ||||||||||||||||||||||||
$6.93 | $6.30 | $2.79 | $5.32 | $3.77 | $3.52 | $5.57 | $(0.78) | $9.87 | ||||||||||||||||
• | “we,” “us,” “company” or “our company” are to Artius II Acquisition Inc., a Cayman Islands exempted company; |
• | “Founder” are to Boon Sim; |
• | “business combination merger agreement” are to the definitive agreement that will govern consummation of the initial business combination; |
• | “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time; |
• | “completion window” are to (i) the period ending on the date that is 18 months from the closing of this offering (or 24 months from the closing of this offering if we have executed a definitive agreement for an initial business combination within 18 months from the closing of this offering) or such earlier liquidation date as our board of directors may approve, in which we must complete an initial business combination or (ii) such other time period in which we must complete an initial business combination pursuant to an amendment to our amended and restated memorandum and articles of association; |
• | “contingent rights to receive distributable shares” are to the contingent rights of holders of our public shares to receive a pro rata share of 1,000,000 (or 1,150,000 if the underwriter’s over-allotment option is exercised in full) Class A ordinary shares at the distribution time, concurrently with the forfeiture by our sponsor of an equal number of founder shares; |
• | “distributable shares” are to the Class A ordinary shares to be distributed at the distribution time on a pro rata basis to public shareholders that do not exercise their redemption right in connection with the initial business combination, concurrently with the forfeiture by our sponsor of an equal number of founder shares; |
• | “distribution time” are to the time at which the distributable shares will be distributed, which will occur substantially concurrently with the closing of our initial business combination upon the satisfaction or waiver of the conditions specified in the business combination merger agreement; |
• | “founder shares” are to Class B ordinary shares initially purchased by our sponsor in a private placement prior to this offering and the Class A ordinary shares that will be issued upon the automatic conversion of the Class B ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described herein (for the avoidance of doubt, such Class A ordinary shares will not be “public shares”); |
• | “initial business combination redemption time” are to the time at which we redeem the Class A ordinary shares that the holders thereof have elected to redeem in connection with our initial business combination, which will occur prior to the consummation of our initial business combination; |
• | “initial shareholders” are to our sponsor and any other holders of our founder shares immediately prior to this offering; |
• | “Investment Company Act” are to the Investment Company Act of 1940, as amended; |
• | “management” or our “management team” are to our officers and directors, including our Founder; |
• | “ordinary resolution” are to a resolution of the company passed by the affirmative vote of a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of the company, or a resolution approved in writing by all of the holders of the issued shares entitled to vote on such matter (or such lower threshold as may be allowed under the Companies Act from time to time); |
• | “ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares; |
• | “private placement rights” are to our rights underlying the private placement units, which are identical to the public rights, subject to certain exceptions; |
• | “private placement shares” are to our Class A ordinary shares underlying the private placement units, which are identical to the public shares, subject to certain exceptions; |
• | “private placement units” are to the units issued to our sponsor in a private placement simultaneously with the closing of this offering; |
• | “public rights” are to the rights to receive one tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination, which are being sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market); |
• | “public shareholders” are to the holders of our public shares, including our initial shareholders, management team or advisors to the extent our initial shareholders, members of our management team, and/or advisors purchase public shares, provided that each initial shareholder’s, member of our management team’s and advisor’s status as a “public shareholder” will only exist with respect to such public shares; |
• | “public shares” are to Class A ordinary shares sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market); |
• | “rights” are to the public rights and private placement rights; |
• | “shares” are to our public shares and private placement shares; |
• | “special advisor” are to Ronald Sugar, who will serve as a special advisor to the company; |
• | “special resolution” are to a resolution of the company passed by at least a two-thirds (2/3) majority (or such higher approval threshold as specified in the company’s amended and restated memorandum and articles of association) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of the company of which notice specifying the intention to propose the resolution as a special resolution has been duly given, or a resolution approved in writing by all of the holders of the issued shares entitled to vote on such matter (or such lower threshold as may be allowed under the Companies Act from time to time); and |
• | “sponsor” are to Artius II Acquisition Partners LLC, Delaware limited liability company which was recently formed to invest in our company, as further discussed under “Sponsor Information”, below. |
• | Karen Richardson | A non-executive director of BP plc (LON: BP) and Exponent, Inc. (NASDAQ: EXPO) |
• | Kevin Costello | An active investor, operator, and advisor to a variety of technology companies. |
• | John Stein | An active investor, advisor and board member to a variety of industrial and technology enabled business services companies. |
• | Need for continued commercial investment in technology to more effectively manage operations and drive growth; |
• | Accelerating B2C and B2B connectivity via mobile, cloud and other digital infrastructures advancements; |
• | Increasing digitization across all industries, including those that address consumer preferences and the automation of operations; and |
• | Expanding use cases for recent technological developments, including data and analytics, new B2B solutions, artificial intelligence and machine learning, edge computing, Internet of Things and 5G. |
• | Deep managerial expertise, with an extensive track record of public market value creation; |
• | Track record of acquisitions, including both bolt-on and transformational acquisitions; |
• | Proprietary sourcing channels, comprising operating executives, financial sponsors, advisors and others; |
• | Ongoing value creation toolkit based on both revenue enhancement and margin expansion; and |
• | Extensive history of accessing the capital markets across various business cycles, including financing businesses and assisting companies with the transition to public ownership. |
• | have a large addressable market with a strong existing or potential customer base; |
• | have a differentiated or unique product and technology offering with multiple avenues for growth and margin expansion; |
• | have strong, experienced management teams, or provide a platform to assemble an effective management team with a track record of driving sustainable growth and profitability; |
• | provide a platform for add-on acquisitions, which we believe will be an opportunity for our sponsor and its members and management team to deliver incremental shareholder value post-acquisition; |
• | have a defensible market position, with demonstrated advantages when compared to their competitors and which create barriers to entry against new competitors; |
• | are at an inflection point, such as requiring additional management expertise, or are able to innovate through new operational techniques, or where we believe we can drive improved financial performance; |
• | have a recurring revenue model and generate high free cash flow; |
• | are fundamentally sound companies that are underperforming their potential; |
• | exhibit unrecognized value or other characteristics, desirable returns on capital, and a need for capital to achieve the company’s growth strategy, that we believe have been mis-valued by the marketplace based on our analysis and due diligence review; |
• | will offer an attractive risk-adjusted return for our shareholders, potential upside from growth in the target business and an improved capital structure that will be weighed against any identified downside risks; and |
• | can benefit from being publicly traded, are prepared to be a publicly traded company, and can utilize access to broader capital markets. |
Entity/Individual | Amount of Compensation to be Received or Securities Issued or to be Issued | Consideration Paid or to be Paid | ||||
Artius II Acquisition Partners LLC | 5,750,000 Class B Ordinary Shares | $25,000 | ||||
175,000 private placement units | $1,750,000 | |||||
Up to $300,000 | Repayment of loans made to us to cover offering related and organizational expenses. | |||||
Up to $1,500,000 in working capital loans, which loans may be convertible into private placement shares of the post-business combination entity, at a price of $10.00 per 1.1 shares, at the option of the lender | Working capital loans to finance transaction costs in connection with an initial business combination. | |||||
Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination | Services related to identifying, investigating, negotiating and completing an initial business combination. | |||||
Artius Management LLC | $25,000 per month | Accounting, bookkeeping, office space, IT support, research, professional, secretarial and administrative services. | ||||
Subject Securities | Expiration Date | Natural Persons and Entities Subject to Restrictions | Exceptions to Transfer Restrictions | ||||||
Founder Shares | The earlier of (i) one year after the completion of our initial business combination or (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, the founder shares will be released from the lockup. | Artius II Acquisition Partners LLC Boon Sim Karen Richardson Kevin Costello John Stein | Transfers permitted (a) to our officers, directors, advisors or consultants, any affiliate or family member of any of our officers, directors, advisors or consultants, any members or partners of the sponsor or their affiliates and funds and accounts advised by such members or partners, any affiliates of the sponsor, or any employees of such affiliates, (b) in the case of an individual, as a gift to such person’s immediate family or to a trust, the beneficiary of which is a member of such person’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such person; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement, in connection with an extension of the completion window or in connection with the consummation of a business combination at prices no greater than the price at which the shares or units were originally purchased; (f) pro rata distributions from our sponsor to its respective members, partners or shareholders pursuant to our sponsor’s limited liability company agreement or other charter documents; (g) by virtue of the laws of the Cayman Islands or our sponsor’s limited liability company agreement upon dissolution of our sponsor , (h) in the event of our liquidation prior to our consummation of our initial business combination; (i) in the event that, subsequent to our consummation of an initial business | ||||||
Subject Securities | Expiration Date | Natural Persons and Entities Subject to Restrictions | Exceptions to Transfer Restrictions | ||||||
combination, we complete a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property or (j) to a nominee or custodian of a person or entity to whom a transfer would be permissible under clauses (a) through (g); provided, however, that in the case of clauses (a) through (g) and clause (j) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreements | |||||||||
Private placement units (including the securities underlying such units) | 30 days after the completion of our initial business combination | Artius II Acquisition Partners LLC | Same as above | ||||||
Any units, rights, ordinary shares or any other securities convertible into, or exercisable, or exchangeable for, ordinary shares | 180 days after the date of this prospectus | Artius II Acquisition Partners LLC Boon Sim Karen Richardson Kevin Costello John Stein | We, our sponsor and our directors and officers have agreed that we and they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, without the prior written consent of Santander US Capital Markets LLC for a period of 180 days after the date of this prospectus, any units, rights, ordinary shares or any other securities convertible into, or exercisable, or exchangeable for, ordinary shares, subject to certain customary exceptions. However, the foregoing shall not apply to the forfeiture of any founder shares pursuant to their terms or any transfer of founder shares to any current or future independent director of the company (as long as such current or future independent director transferee is subject to the letter agreement, filed herewith, or executes an agreement substantially | ||||||
Subject Securities | Expiration Date | Natural Persons and Entities Subject to Restrictions | Exceptions to Transfer Restrictions | ||||||
identical to the letter agreement, as applicable to directors and officers at the time of such transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result of such transfer, any related Section 16 filing includes a practical explanation as to the nature of the transfer). Santander US Capital Markets LLC in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice. | |||||||||
• | one Class A ordinary share; |
• | one right to receive one tenth (1/10) of one Class A ordinary share upon the consummation of an initial business combination; and |
• | one contingent right to receive distributable shares. |
Public Shares Redeemed | ||||||||||||
0% | 25% | 50% | 75% | |||||||||
Distributable shares received(1) | 5 | 6.7 | 10 | 20 | ||||||||
(1) | Approximate number of distributable shares received by a non-redeeming shareholder of 100 Class A ordinary shares. |
(1) | Assumes no exercise of the underwriter’s over-allotment option and 750,000 founder shares are surrendered to us for no consideration. |
(2) | Includes up to 750,000 founder shares that will be surrendered to us for no consideration depending on the extent to which the underwriter’s over-allotment option is exercised. |
(3) | Comprised of 20,000,000 Class A ordinary shares included in the units to be sold in this offering, 175,000 private placement shares underlying the private placement units to be sold to our sponsor in a private placement simultaneously with this offering, and 5,000,000 Class B ordinary shares (or founder shares). Founder shares are currently classified as Class B ordinary shares, which shares will automatically convert into Class A ordinary shares in connection with the consummation of our initial business combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment as described below adjacent to the caption “Founder shares conversion and anti-dilution rights.” |
(4) | Assumes surrender of 750,000 founder shares. Up to 750,000 founder shares will be surrendered to us for no consideration depending on the extent to which the underwriter’s over-allotment option is exercised. |
(5) | Comprised of 20,000,000 public rights included in the public units to be sold in this offering and 175,000 private placement rights to be sold to our sponsor in a private placement simultaneously with this offering. |
• | prior to the closing of our initial business combination, only holders of our Class B ordinary shares have the right to vote on the appointment or removal of directors and on continuing the company in a jurisdiction outside the Cayman Islands (as further described herein), prior to the consummation of our initial business combination; |
• | the founder shares are subject to certain transfer restrictions, as described in more detail below; |
• | the founder shares are entitled to registration rights; |
• | the founder shares are automatically convertible into our Class A ordinary shares in connection with the consummation of our initial business combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described below adjacent to the caption “Founder shares conversion and anti-dilution rights”; and |
• | our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with the completion of our initial business combination; (ii) waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination within the completion window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity; (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares and private placement shares if we fail to complete our |
• | net proceeds of this offering and the sale of the private placement units not held in the trust account; and |
• | any loans or additional investments from our sponsor, members of our management team or their affiliates or other third parties, although they are under no obligation to advance funds or invest in us; provided that any such loans will not have any claim on the proceeds held in the trust account unless such proceeds are released to us upon completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement shares of the post-business combination entity, at a price of $10.00 per 1.1 shares, at the option of the lender. |
• | our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that our sponsor, initial shareholders, directors, officers, advisors or their affiliates may purchase shares or rights from public shareholders outside the redemption process, along with the purpose of such purchases; |
• | if our sponsor, initial shareholders, directors, officers, advisors or their affiliates were to purchase shares or rights from public shareholders, they would do so at a price no higher than the price offered through our redemption process; |
• | our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by our sponsor, initial shareholders, directors, officers, advisors or their affiliates would not be voted in favor of approving the business combination transaction; |
• | our sponsor, initial shareholders, directors, officers, advisors or their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and |
• | we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items: |
• | the amount of our securities purchased outside of the redemption offer by our sponsor, initial shareholders, directors, officers, advisors or their affiliates, along with the purchase price; |
• | the purpose of the purchases by our sponsor, initial shareholders, directors, officers, advisors or their affiliates; |
• | the impact, if any, of the purchases by our sponsor, initial shareholders, directors, officers, advisors or their affiliates on the likelihood that the business combination transaction will be approved; |
• | the identities of our security holders who sold to our sponsor, initial shareholders, directors, officers, advisors or their affiliates (if not purchased on the open market) or the nature of our security holders (e.g., 5% security holders) who sold to our sponsor, initial shareholders, directors, officers, advisors or their affiliates; and |
• | the number of our securities for which we have received redemption requests pursuant to our redemption offer. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
• | Repayment of up to an aggregate of $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses; |
• | Payment of consulting, legal, success or finder fees to our independent directors, advisors, or their respective affiliates in connection with the consummation of our initial business combination; |
• | We may engage our sponsor or an affiliate of our sponsor as an advisor or otherwise in connection with our initial business combination and certain other transactions and pay such person or entity a salary or fee in an amount that constitutes a market standard for comparable transactions; |
• | Reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination; and |
• | Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement shares of the post-business combination entity at a price of $10.00 per 1.1 shares at the option of the lender. Such shares would be identical to the private placement shares. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. |
December 31, 2024 | ||||||
Actual | As Adjusted | |||||
Balance Sheet Data: | ||||||
Working capital deficiency(1) | $(563,944) | $393,826 | ||||
Total assets(2) | $503,670 | $200,689,726 | ||||
Total liabilities(3) | $563,944 | $12,295,900 | ||||
Value of ordinary share subject to possible redemption(4) | $— | $200,000,000 | ||||
Shareholders’ equity (deficit)(5) | $(60,274) | $(11,606,174) | ||||
(1) | The “as adjusted” calculation includes $750,000 of funds held outside of trust, plus $60,274 of actual shareholders’ deficit on December 31, 2024, less $295,900 of over-allotment liability. |
(2) | The “as adjusted” calculation equals $200,000,000 of cash held in trust from the proceeds of this offering and the sale of the private placement units, plus $750,000 of funds held outside of trust, less $60,274 of actual shareholders’ deficit on December 31, 2024. |
(3) | The “as adjusted” calculation equals $6,000,000 of deferred underwriting commissions, assuming the over-allotment option is not exercised, plus the over-allotment liability of $295,900, plus the $6,000,000 advisory fee payable to Santander US Capital Markets LLC upon and subject to the closing of our initial business combination. |
(4) | Represents the 20,000,000 ordinary shares at $10.00 per share sold in the offering. |
(5) | Excludes 20,000,000 ordinary shares purchased in the public market which are subject to conversion in connection with our initial business combination. The “as adjusted” calculation equals the “as adjusted” total assets, less the “as adjusted” total liabilities, less the value of ordinary shares that may be converted in connection with our initial business combination ($10.00 per share). |
• | We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Our public shareholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders of our founder shares and private placement shares will participate in such vote, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination. |
• | Your only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
• | Our sponsor will control the appointment of our board of directors until consummation of our initial business combination and will hold a substantial interest in us. As a result, it will appoint all of our directors prior to the consummation of our initial business combination and may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support. |
• | If we seek shareholder approval of our initial business combination, our initial shareholders and management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote. |
• | If you elect to exercise your redemption rights with respect to your Class A ordinary shares, you will be deemed to have tendered your contingent rights to received distributable shares for no additional consideration, and as a result are not entitled to receive any distribution of distributable shares in respect of such redeemed public shares. |
• | The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares and the amount of deferred underwriting compensation may not allow us to complete the most desirable business combination or optimize our capital structure, and may substantially dilute your investment in us. |
• | The requirement that we complete our initial business combination within the completion window may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders. |
• | If we seek shareholder approval of our initial business combination, our sponsor, initial shareholders, directors, officers, advisors and their affiliates may elect to purchase shares or rights from public shareholders, which may influence a vote on a proposed business combination and reduce the public “float” of our Class A ordinary shares or rights. |
• | Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.” |
• | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or rights, potentially at a loss. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline. |
• | The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary at such time is substantially less than $10.00 per share. |
• | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
• | If the net proceeds of this offering and the sale of the private placement units not held in the trust account are insufficient to allow us to operate for at least the duration of the completion window, it could limit the amount available to fund our search for a target business or businesses and complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or our management team to fund our search and to complete our initial business combination. |
• | Past performance by our management team, our advisors and their respective affiliates, including investments and transactions in which they have participated and businesses with which they have been associated, may not be indicative of future performance of an investment in the company. |
• | We may be a passive foreign investment company, or “PFIC,” which could result in adverse United States federal income tax consequences to U.S. investor. |
• | To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the trust account, we may, at any time (based on our management team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank until the earlier of the consummation of our initial business combination or our liquidation. As a result, following the liquidation of investments in the trust account, we would likely receive less interest on the funds held in the trust account, which would likely reduce the dollar amount our public shareholders would receive upon any redemption or liquidation. |
• | Depending on the details of our initial business combination, a U.S. federal excise tax could be imposed on us in connection with any redemptions of our Class A ordinary shares in connection with such initial business combination. |
• | If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination. |
• | Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations. |
• | Our search for an initial business combination, and any target business with which we may ultimately consummate an initial business combination, may be materially adversely affected by current global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the conflict in the Middle East and Southwest Asia. |
• | Military or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect the operations or financial condition of potential target companies, which could make it more difficult for us to consummate an initial business combination. |
• | We may reincorporate in or transfer by way of continuation to another jurisdiction which may result in taxes imposed on shareholders and/or right holders. |
• | The other risks and uncertainties discussed in “Risk Factors” and elsewhere in this prospectus. |
• | our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that our sponsor, initial shareholders, directors, officers, advisors and their affiliates may purchase public shares or rights from public shareholders outside the redemption process, along with the purpose of such purchases; |
• | if our sponsor, initial shareholders, directors, officers, advisors and their affiliates were to purchase public shares or rights from public shareholders, they would do so at a price no higher than the price offered through our redemption process; |
• | our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by our sponsor, initial shareholders, directors, officers, advisors and their affiliates would not be voted in favor of approving the business combination transaction; |
• | our sponsor, initial shareholders, directors, officers, advisors and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and |
• | we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items: |
○ | the amount of our securities purchased outside of the redemption offer by our sponsor, initial shareholders, directors, officers, advisors and their affiliates, along with the purchase price; |
○ | the purpose of the purchases by our sponsor, initial shareholders, directors, officers, advisors and their affiliates; |
○ | the impact, if any, of the purchases by our sponsor, initial shareholders, directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be approved; |
○ | the identities of our security holders who sold to our sponsor, initial shareholders, directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security holders (e.g., 5% security holders) who sold to our sponsor, initial shareholders, directors, officers, advisors and their affiliates; and |
○ | the number of our securities for which we have received redemption requests pursuant to our redemption offer. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
• | registration as an investment company; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
• | may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and |
• | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or rights. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of Nasdaq; and |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset, or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | costs and difficulties inherent in managing cross-border business operations; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | challenges in managing and staffing international operations; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters, widespread health emergencies and wars; and |
• | deterioration of political relations with the United States. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
Public shares(1) | 20,000,000 | ||
Private placement shares(2) | 175,000 | ||
Founder shares(3) | 5,000,000 | ||
Shares issuable upon conversion of public rights | 2,000,000 | ||
Shares issuable upon conversion of private placement rights | 17,500 | ||
Total shares | 27,192,500 | ||
Total funds in trust available for initial business combination(4) | $188,000,000 | ||
Public shareholders’ investment per Class A ordinary share(5) | $10.00 | ||
Sponsor’s investment per Class B ordinary share(6) | $0.005 | ||
Initial implied value per public share(7) | $9.40 | ||
Implied value per share upon consummation of initial business combination(3) | $6.91 | ||
(1) | Does not include the additional 2,000,000 Class A ordinary shares issuable upon conversion of the 20,000,000 public rights upon the consummation of an initial business combination. |
(2) | Does not include the additional 17,500 Class A ordinary shares issuable upon conversion of the 175,000 private placement rights upon the consummation of an initial business combination. |
(3) | All founder shares would automatically convert into Class A ordinary shares upon completion of our initial business combination or earlier at the option of the holder on a one-for-one basis. |
(4) | Total funds in trust available for initial business combination reduced by $0.30 per unit on all units sold ($6,000,000 in the aggregate or up to $6,900,000 in the aggregate if the underwriter’s over-allotment option is exercised in full) payable to the underwriter for deferred underwriting commissions and the $6,000,000 advisory fee payable to Santander US Capital Markets LLC upon and subject to the closing of our initial business combination. |
(5) | While the public shareholders’ investment is in both the public shares and the public rights, for purposes of this table the full investment amount is ascribed to the public shares only and assumes no distribution of distributable shares. |
(6) | The total investment in the equity of the company by the sponsor is $1,775,000, consisting of (i) $25,000 paid by the sponsor for the founder shares and (ii) $1,750,000 paid by the sponsor for 175,000 private placement units. For purposes of this table, the sponsor’s investment in the private placement units has been disregarded as it is assumed to be consumed for working capital purposes prior to the initial business combination. |
(7) | Initial implied value per public share is defined as the funds available for the initial business combination (assuming the underwriters’ over-allotment option is not exercised and following payment of the underwriters’ deferred fee) divided by the public shares issued of 20,000,000 (assuming the underwriters’ over-allotment option is not exercised). |
• | the history and prospects of companies whose principal business is the acquisition of other companies; |
• | prior offerings of those companies; |
• | our prospects for acquiring an operating business at attractive values; |
• | a review of debt to equity ratios in leveraged transactions; |
• | our capital structure; |
• | an assessment of our management and their experience in identifying operating companies; |
• | general conditions of the securities markets at the time of this offering; and |
• | other factors as were deemed relevant. |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of the prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | the adverse impacts of certain events (such as terrorist attacks, natural disasters or a significant outbreak of infectious diseases) on our ability to consummate an initial business combination; |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of net proceeds of this offering and the sale of the private placement units not held in the trust account; |
• | the trust account not being subject to claims of third parties; or |
• | our financial performance following this offering. |
Without Over-allotment Option | Over-allotment Option Exercised | |||||
Gross proceeds | ||||||
Gross proceeds from units offered to public(1) | $200,000,000 | $230,000,000 | ||||
Gross proceeds from private placement units offered in the private placement | $1,750,000 | $1,750,000 | ||||
Total gross proceeds | $201,750,000 | $231,750,000 | ||||
Offering expenses(2) | ||||||
Underwriting commissions (excluding the deferred portions)(3) | $250,000 | $250,000 | ||||
Legal fees and expenses | 400,000 | 400,000 | ||||
Printing and engraving expenses | 35,000 | 35,000 | ||||
Trustee fees and expenses | 8,000 | 8,000 | ||||
Accounting fees and expenses | 75,000 | 75,000 | ||||
SEC/FINRA expenses | 90,000 | 90,000 | ||||
Travel and road show expenses | 5,000 | 5,000 | ||||
Nasdaq listing fees | 85,000 | 85,000 | ||||
Miscellaneous | 52,000 | 52,000 | ||||
Total offering expenses (other than underwriting commissions) | $750,000 | $750,000 | ||||
Proceeds after offering expenses | $200,750,000 | $230,750,000 | ||||
Held in trust account(3) | $200,000,000 | $230,000,000 | ||||
% of public offering size | 100% | 100% | ||||
Amount | % of Total | |||||
Accounting, due diligence, travel, and other expenses in connection with any business combination | $150,000 | 12% | ||||
Legal and accounting fees related to regulatory reporting obligations | 175,000 | 14% | ||||
Payment to an affiliate of our sponsor for accounting, bookkeeping, office space, IT support, research, professional, secretarial and administrative services(5) | 300,000 | 24% | ||||
Nasdaq and other regulatory fees | 81,000 | 6.5% | ||||
Directors’ and officers’ liability insurance | 350,000 | 28% | ||||
Working capital to cover miscellaneous expenses(6) | 194,000 | 15.5% | ||||
Total | $1,250,000 | 100% | ||||
(1) | Includes amounts payable to public shareholders who properly redeem their shares in connection with our successful completion of our initial business combination. |
(2) | Prior to the closing of this offering, our sponsor agreed to loan us up to $300,000 to be used for a portion of the expenses of this offering. These loans are non-interest bearing, unsecured and will be repaid from either (i) the $750,000 of offering proceeds that has been allocated to the payment of offering expenses or (ii) amounts available for working capital. In the event that offering expenses are less than set forth in this table, any such amounts will be used for post-closing working capital expenses. |
(3) | Underwriting commissions include $250,000 (such amount to remain unchanged in the event to the underwriter’s over-allotment option is exercised in full) payable to the underwriter upon the closing of this offering. The underwriter has also agreed to defer $0.3 per unit on all units sold. Upon completion of our initial business combination, $6,000,000 in the aggregate (or up to $6,900,000 in the aggregate if the underwriter’s over-allotment option is exercised in full), assuming payment of $0.3 per unit on all units sold, will be paid to the underwriter from the funds held in the trust account. Such deferred underwriting commissions will not be payable with respect to any shares redeemed |
(4) | These expenses are estimates only. Our actual expenditures for some or all of these items may differ from the estimates set forth herein. For example, we may incur greater legal and accounting expenses than our current estimates in connection with negotiating and structuring our initial business combination based upon the level of complexity of such business combination. In the event we identify a business combination target in a specific industry subject to specific regulations, we may incur additional expenses associated with legal due diligence and the engagement of special legal counsel. In addition, our staffing needs may vary and as a result, we may engage a number of consultants to assist with legal and financial due diligence. We do not anticipate any change in our intended use of proceeds, other than fluctuations among the current categories of allocated expenses, which fluctuations, to the extent they exceed current estimates for any specific category of expenses, would not be available for our expenses. |
(5) | Represents $25,000 per month payable to an affiliate of our sponsor for accounting, bookkeeping, office space, IT support, research, professional, secretarial and administrative services for 12 months. In the event that we require additional time to consummate our initial business combination, such expenses may increase and be paid from net proceeds of this offering and the sale of the private placement units not held in the trust account or from working capital loans. |
(6) | A portion of these amounts may be used to repay amounts due under the promissory note made out to our sponsor of up to $300,000, as described in this prospectus. |
As of December 31, 2024 | ||||||||||||||||||||||||
Deemed Offering Price of $9.09 per Unit | 25% of Maximum Redemption | 50% of Maximum Redemption | 75% of Maximum Redemption | Maximum Redemption | ||||||||||||||||||||
NTBV | NTBV | Difference between NTBV and Offering Price | NTBV | Difference between NTBV and Offering Price | NTBV | Difference between NTBV and Offering Price | NTBV | Difference between NTBV and Offering Price | ||||||||||||||||
Assuming Full Exercise of Over-Allotment Option | ||||||||||||||||||||||||
$6.97 | $6.36 | $2.73 | $5.38 | $3.71 | $3.61 | $5.48 | $(0.64) | $9.73 | ||||||||||||||||
Assuming No Exercise of Over-Allotment Option | ||||||||||||||||||||||||
$6.93 | $6.30 | $2.79 | $5.32 | $3.77 | $3.52 | $5.57 | $(0.78) | $9.87 | ||||||||||||||||
As of December 31, 2024 | ||||||||||||||||||||||||
25% of Maximum Redemption | 50% of Maximum Redemption | 75% of Maximum Redemption | 100% of Maximum Redemption | |||||||||||||||||||||
No Over- allotment | Full Over- allotment | No Over- allotment | Full Over- allotment | No Over- allotment | Full Over- allotment | No Over- allotment | Full Over- allotment | |||||||||||||||||
Deemed public offering price(1) | $9.09 | $9.09 | $9.09 | $9.09 | $9.09 | $9.09 | $9.09 | $9.09 | ||||||||||||||||
Net tangible book value deficit before this offering | (0.10) | (0.10) | (0.10) | (0.10) | (0.10) | (0.10) | (0.10) | (0.10) | ||||||||||||||||
Increase (decrease) attributable to public shareholders | $6.40 | 6.46 | 5.42 | 5.48 | 3.62 | 3.71 | (0.68) | (0.54) | ||||||||||||||||
Pro forma net tangible book value after this offering | $6.30 | 6.36 | 5.32 | 5.38 | 3.52 | 3.61 | (0.78) | (0.64) | ||||||||||||||||
Dilution to public shareholders | $2.79 | 2.73 | 3.77 | 3.71 | 5.57 | 5.48 | 9.87 | 9.73 | ||||||||||||||||
% Dilution to public shareholders | 30.70% | 30.04% | 41.48% | 40.82% | 61.28% | 60.29% | 108.58% | 107.04% | ||||||||||||||||
Numerator: | ||||||||||||||||||||||||
Net tangible book value deficit before this offering | $(563,944) | $(563,944) | $(563,944) | $(563,944) | $(563,944) | $(563,944) | $(563,944) | $(563,944) | ||||||||||||||||
Net proceeds from this offering and the sale of private placement units(2) | $200,750,000 | 230,750,000 | 200,750,000 | 230,750,000 | 200,750,000 | 230,750,000 | 200,750,000 | 230,750,000 | ||||||||||||||||
Plus: Offering costs accrued for or paid in advance, excluded from tangible book value | $503,670 | 503,670 | 503,670 | 503,670 | 503,670 | 503,670 | 503,670 | 503,670 | ||||||||||||||||
Less: Over-allotment liability | $(295,900) | — | $(295,900) | — | $(295,900) | — | $(295,900) | — | ||||||||||||||||
Less: Deferred underwriting commission(3) | $(4,500,000) | $(5,175,000) | $(3,000,000) | $(3,450,000) | $(1,500,000) | $(1,725,000) | $— | $— | ||||||||||||||||
Less: Advisory Fee(3) | $(6,000,000) | $(6,000,000) | $(6,000,000) | $(6,000,000) | $(6,000,000) | $(6,000,000) | $(6,000,000) | $(6,000,000) | ||||||||||||||||
Less: Redemptions(4) | $(50,000,000) | (57,500,000) | (100,000,000) | (115,000,000) | (150,000,000) | (172,500,000) | (200,000,000) | (230,000,000) | ||||||||||||||||
Total | $139,893,826 | 162,014,726 | 91,393,826 | 106,239,726 | 42,893,826 | 50,464,726 | (5,606,174) | (5,310,274) | ||||||||||||||||
Denominator: | ||||||||||||||||||||||||
Ordinary shares outstanding prior to this offering | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 | ||||||||||||||||
Ordinary shares forfeited if over-allotment is not exercised | (750,000) | — | (750,000) | — | (750,000) | — | (750,000) | — | ||||||||||||||||
Ordinary shares offered | 20,000,000 | 23,000,000 | 20,000,000 | 23,000,000 | 20,000,000 | 23,000,000 | 20,000,000 | 23,000,000 | ||||||||||||||||
Shares underlying public rights | 2,000,000 | 2,300,000 | 2,000,000 | 2,300,000 | 2,000,000 | 2,300,000 | 2,000,000 | 2,300,000 | ||||||||||||||||
Private placement shares | 175,000 | 175,000 | 175,000 | 175,000 | 175,000 | 175,000 | 175,000 | 175,000 | ||||||||||||||||
Shares underlying private placement rights | 17,500 | 17,500 | 17,500 | 17,500 | 17,500 | 17,500 | 17,500 | 17,500 | ||||||||||||||||
Less: Ordinary shares redeemed | (5,000,000) | (5,750,000) | (10,000,000) | (11,500,000) | (15,000,000) | (17,250,000) | (20,000,000) | (23,000,000) | ||||||||||||||||
Distributable shares | 1,000,000 | 1,150,000 | 1,000,000 | 1,150,000 | 1,000,000 | 1,150,000 | 1,000,000 | 1,150,000 | ||||||||||||||||
Less: Founder shares forfeited equal to the distributable shares | (1,000,000) | (1,150,000) | (1,000,000) | (1,150,000) | (1,000,000) | (1,150,000) | (1,000,000) | (1,150,000) | ||||||||||||||||
Total | 22,192,500 | 25,492,500 | 17,192,500 | 19,742,500 | 12,192,500 | 13,992,500 | 7,192,500 | 8,242,500 |
(1) | Offering price per unit after taking into account the shares issuable upon conversion of the rights. |
(2) | Expenses applied against gross proceeds include offering expenses of approximately $750,000 and $250,000 payable to the underwriter upon the closing of this offering. See “Use of Proceeds.” |
(3) | Upon the consummation of our initial business combination, $0.30 per unit on all units sold ($6,000,000 in the aggregate or up to $6,900,000 in the aggregate if the underwriter’s over-allotment option is exercised in full) will be payable to the underwriter for deferred underwriting. Such deferred commissions may be paid at the sole and absolute discretion of our management team to any one or more FINRA members, which may or may not include the underwriter. See also “Underwriting” for a description of compensation and other items of value payable to the underwriter. In addition, an advisory fee of $6,000,000 is payable to Santander US Capital Markets LLC upon and subject to the closing of our initial business combination. |
(4) | If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, Founder, initial shareholders, directors, executive officers or their affiliates may purchase shares or public rights in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of Class A ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Effecting Our Initial Business Combination—Permitted Purchases of Our Securities.” |
December 31, 2024 | ||||||
Actual | As Adjusted | |||||
Notes payable to related party(1) | $127,615 | $— | ||||
Advisory Fee(2) | 6,000,000 | |||||
Deferred underwriting commissions | — | 6,000,000 | ||||
Class A ordinary shares, subject to redemption, 0 and 20,000,000 shares which are subject to possible redemption, actual and as adjusted, respectively(3) | — | 200,000,000 | ||||
Over-allotment liability | — | 295,900 | ||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding, actual and as adjusted | — | — | ||||
Class A ordinary shares, $0.0001 par value, 400,000,000 shares authorized; 0 and 175,000 shares issued and outstanding, actual and as adjusted | — | 18 | ||||
Class B ordinary shares, $0.0001 par value, 50,000,000 shares authorized, 5,750,000 and 5,000,000 shares issued and outstanding, actual and as adjusted, respectively(4) | 575 | 500 | ||||
Additional paid-in capital | 24,425 | — | ||||
Accumulated deficit | (85,274) | (11,606,692) | ||||
Total shareholders’ equity (deficit) | $(60,274) | $(11,606,174) | ||||
Total capitalization | $67,341 | $200,689,726 | ||||
(1) | Our sponsor may loan us up to $300,000 under an unsecured promissory note to be used for a portion of the expenses of this offering. The “as adjusted” information gives effect to the repayment of any loans received from our sponsor out of the proceeds from this offering and the sale of the private placement units. As of December 31, 2024, we had borrowed $127,615 under the promissory note with our sponsor. |
(2) | An advisory fee of $6,000,000 shall be payable to Santander US Capital Markets LLC upon and subject to the closing of our initial business combination. |
(3) | Upon the completion of our initial business combination, we will provide our public shareholders with the opportunity to redeem their public shares, regardless of whether they abstain, vote for, or vote against, our initial business combination, for cash at a per share price equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account (net of taxes payable), divided by the number of then-outstanding public shares, subject to any limitations (including, but not limited to, cash requirements) created by the terms of the proposed business combination. The ordinary shares offered to the public contain redemption rights that make them redeemable by our public shareholders. Accordingly, they are classified within temporary equity in accordance with the guidance provided in ASC 480-10-S99-3A and will be subsequently accreted to their redemption value. |
(4) | Actual share amount is prior to any forfeiture of founder shares and as adjusted amount assumes no exercise of the underwriter’s over-allotment option (and related forfeiture of an aggregate of 750,000 founder shares), and excludes the 175,000 private placement shares, the distribution of distributable shares and forfeiture of founder shares concurrently therewith. |
• | may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
• | could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and |
• | may adversely affect prevailing market prices for our Class A ordinary shares and/or rights. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | staffing for financial, accounting and external reporting areas, including segregation of duties; |
• | reconciliation of accounts; |
• | proper recording of expenses and liabilities in the period to which they relate; |
• | evidence of internal review and approval of accounting transactions; |
• | documentation of processes, assumptions and conclusions underlying significant estimates; and |
• | documentation of accounting policies and procedures. |
• | Karen Richardson | A non-executive director of BP plc (LON: BP) and Exponent, Inc. (NASDAQ: EXPO). |
• | Kevin Costello | An active investor, operator, and advisor to a variety of technology companies. |
• | John Stein | An active investor, advisor and board member to a variety of industrial and technology enabled business services companies. |
• | Need for continued commercial investment in technology to more effectively manage operations and drive growth; |
• | Accelerating B2C and B2B connectivity via mobile, cloud and other digital infrastructures advancements; |
• | Increasing digitization across all industries, including those that address consumer preferences and the automation of operations; and |
• | Expanding use cases for recent technological developments, including data and analytics, new B2B solutions, artificial intelligence and machine learning, edge computing, Internet of Things and 5G. |
• | Deep managerial expertise, with an extensive track record of public market value creation; |
• | Track record of acquisitions, including both bolt-on and transformational acquisitions; |
• | Proprietary sourcing channels, comprising operating executives, financial sponsors, advisors and others; |
• | Ongoing value creation toolkit based on both revenue enhancement and margin expansion; and |
• | Extensive history of accessing the capital markets across various business cycles, including financing businesses and assisting companies with the transition to public ownership. |
• | have a large addressable market with a strong existing or potential customer base; |
• | have a differentiated or unique product and technology offering with multiple avenues for growth and margin expansion; |
• | have strong, experienced management teams, or provide a platform to assemble an effective management team with a track record of driving sustainable growth and profitability; |
• | provide a platform for add-on acquisitions, which we believe will be an opportunity for our sponsor and its members and management team to deliver incremental shareholder value post-acquisition; |
• | have a defensible market position, with demonstrated advantages when compared to their competitors and which create barriers to entry against new competitors; |
• | are at an inflection point, such as requiring additional management expertise, or are able to innovate through new operational techniques, or where we believe we can drive improved financial performance; |
• | have a recurring revenue model and generate high free cash flow; |
• | are fundamentally sound companies that are underperforming their potential; |
• | exhibit unrecognized value or other characteristics, desirable returns on capital, and a need for capital to achieve the company’s growth strategy, that we believe have been mis-valued by the marketplace based on our analysis and due diligence review; |
• | will offer an attractive risk-adjusted return for our shareholders, potential upside from growth in the target business and an improved capital structure that will be weighed against any identified downside risks; and |
• | can benefit from being publicly traded, are prepared to be a publicly traded company, and can utilize access to broader capital markets. |
Entity/Individual | Amount of Compensation to be Received or Securities Issued or to be Issued | Consideration Paid or to be Paid | ||||
Artius II Acquisition Partners LLC | 5,750,000 Class B Ordinary Shares | $25,000 | ||||
175,000 private placement units | $1,750,000 | |||||
Up to $300,000 | Repayment of loans made to us to cover offering related and organizational expenses. | |||||
Up to $1,500,000 in working capital loans, which loans may be convertible into private placement shares of the post-business combination entity, at a price of $10.00 per 1.1 shares, at the option of the lender | Working capital loans to finance transaction costs in connection with an initial business combination. | |||||
Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination | Services related to identifying, investigating, negotiating and completing an initial business combination. | |||||
Artius Management LLC | $25,000 per month | Accounting, bookkeeping, office space, IT support, research, professional, secretarial and administrative services. | ||||
Subject Securities | Expiration Date | Natural Persons and Entities Subject to Restrictions | Exceptions to Transfer Restrictions | ||||||
Founder Shares | The earlier of (i) one year after the completion of our initial business combination or (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, the founder shares will be released from the lock-up. | Artius II Acquisition Partners LLC Boon Sim Karen Richardson Kevin Costello John Stein | Transfers permitted (a) to our officers, directors, advisors or consultants, any affiliate or family member of any of our officers, directors, advisors or consultants, any members or partners of the sponsor or their affiliates and funds and accounts advised by such members or partners, any affiliates of the sponsor, or any employees of such affiliates, (b) in the case of an individual, as a gift to such person’s immediate family or to a trust, the beneficiary of which is a member of such person’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such person; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement, in connection with an extension of the completion window or in connection with the consummation of a business combination at prices no greater than the price at which the shares or units were originally purchased; (f) pro rata distributions from our sponsor to its respective members, partners or shareholders pursuant to our sponsor’s limited liability company agreement or other charter documents; (g) by virtue of the laws of the Cayman Islands or our sponsor’s limited liability company agreement upon dissolution of our sponsor , (h) in the event of our liquidation prior to our consummation of our initial business combination; (i) in the event that, subsequent to our consummation of an initial business | ||||||
Subject Securities | Expiration Date | Natural Persons and Entities Subject to Restrictions | Exceptions to Transfer Restrictions | ||||||
combination, we complete a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property or (j) to a nominee or custodian of a person or entity to whom a transfer would be permissible under clauses (a) through (g); provided, however, that in the case of clauses (a) through (g) and clause (j) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreements | |||||||||
Private placement units (including the securities underlying such units) | 30 days after the completion of our initial business combination | Artius II Acquisition Partners LLC | Same as above | ||||||
Any units, rights, ordinary shares or any other securities convertible into, or exercisable, or exchangeable for, ordinary shares | 180 days after the date of this prospectus | Artius II Acquisition Partners LLC Boon Sim Karen Richardson Kevin Costello John Stein | We, our sponsor and our directors and officers have agreed that we and they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, without the prior written consent of Santander US Capital Markets LLC for a period of 180 days after the date of this prospectus, any units, rights, ordinary shares or any other securities convertible into, or exercisable, or exchangeable for, ordinary shares, subject to certain customary exceptions. However, the foregoing shall not apply to the forfeiture of any founder shares pursuant to their terms or any transfer of founder shares to any current or future independent director of the company (as long as such current or future independent director transferee is subject to the letter agreement, filed herewith, or executes an agreement substantially | ||||||
Subject Securities | Expiration Date | Natural Persons and Entities Subject to Restrictions | Exceptions to Transfer Restrictions | ||||||
identical to the letter agreement, as applicable to directors and officers at the time of such transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result of such transfer, any related Section 16 filing includes a practical explanation as to the nature of the transfer). Santander US Capital Markets LLC in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice. | |||||||||
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | We issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then outstanding (other than in a public offering); |
• | Any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater interest earned on the trust account (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in outstanding ordinary shares or voting power of 5% or more; or |
• | The issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
• | our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that our sponsor, initial shareholders, directors, officers, advisors and their affiliates may purchase public shares or rights from public shareholders outside the redemption process, along with the purpose of such purchases; |
• | if our sponsor, initial shareholders, directors, officers, advisors and their affiliates were to purchase public shares or rights from public shareholders, they would do so at a price no higher than the price offered through our redemption process; |
• | our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by our sponsor, initial shareholders, directors, officers, advisors and their affiliates would not be voted in favor of approving the business combination transaction; |
• | our sponsor, initial shareholders, directors, officers, advisors and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and |
• | we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items: |
• | the amount of our securities purchased outside of the redemption offer by our sponsor, initial shareholders, directors, officers, advisors and their affiliates, along with the purchase price; |
• | the purpose of the purchases by our sponsor, initial shareholders, directors, officers, advisors and their affiliates; |
• | the impact, if any, of the purchases by our sponsor, initial shareholders, directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be approved; |
• | the identities of our security holders who sold to our sponsor, initial shareholders, directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security holders (e.g., 5% security holders) who sold to our sponsor, initial shareholders, directors, officers, advisors and their affiliates; and |
• | the number of our securities for which we have received redemption requests pursuant to our redemption offer. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
Redemptions in Connection with our Initial Business Combination | Other Permitted Purchases of Public Shares by our Affiliates | Redemptions if we fail to Complete an Initial Business Combination | |||||||
Calculation of redemption price | Redemptions at the time of our initial business combination may be made pursuant to a tender offer or in connection with a shareholder vote. The redemption price will be the same whether we conduct redemptions pursuant to a tender offer or in connection with a shareholder vote. In either case, our public shareholders may redeem their public shares for cash equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination (which is initially anticipated to be $10.00 per share), including interest earned on the funds held in the trust account (net of taxes payable), divided by the number of then-outstanding public shares, subject to the limitation that no redemptions will take place if all of the redemptions would cause to be unable to satisfy any limitations (including, but not limited to, cash requirements) agreed to in connection with the negotiation of terms of a proposed business combination. | If we seek shareholder approval of our initial business combination, our sponsor, initial shareholders, directors, officers, advisors or their affiliates may purchase shares or rights in privately negotiated transactions or in the open market either prior to or following completion of our initial business combination. If our sponsor, initial shareholders, directors, officers, advisors or their affiliates were to purchase shares or rights from public shareholders, they would do so at a price no higher than the price offered through our redemption process. If they engage in such transactions they will not make any such purchases when they are in possession of any material nonpublic information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act. We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will comply with such rules. | If we are unable to complete our initial business combination within the completion window, we will redeem all public shares at a per-share price, payable in cash, equal to the aggregate amount, then on deposit in the trust account (which is initially anticipated to be $10.00 per share), including interest earned on the funds held in the trust account and not previously released to us (net of taxes payable and up to $100,000 of interest to pay liquidation and dissolution expenses) divided by the number of then-outstanding public shares. | ||||||
Redemptions in Connection with our Initial Business Combination | Other Permitted Purchases of Public Shares by our Affiliates | Redemptions if we fail to Complete an Initial Business Combination | |||||||
Impact to remaining shareholders | The redemptions in connection with our initial business combination will reduce the book value per share for our remaining shareholders, who will bear the burden of the deferred underwriting commissions. | If the permitted purchases described above are made, there would be no impact to our remaining shareholders because the purchase price would not be paid by us. | The redemption of our public shares if we fail to complete our initial business combination will reduce the book value per share for the shares held by our initial shareholders, who will be our only remaining shareholders after such redemptions. | ||||||
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
Escrow of offering proceeds | $200,000,000 of the net proceeds of this offering and the sale of the private placement units will be deposited into a trust account located in the United States with Continental Stock Transfer & Trust Company acting as trustee. | Approximately $188,750,000 of the offering proceeds, representing the gross proceeds of this offering and the sale of the private placement units, would be required to be deposited into either an escrow account with an insured depositary institution or in a separate bank account established by a broker-dealer in which the broker-dealer acts as trustee for persons having the beneficial interests in the account. | ||||
Investment of net proceeds | $200,000,000 of the net proceeds of this offering and the sale of the private placement units held in trust will initially be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended business combination. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the trust account, we may, at any time (based on our management team’s ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the trust | Proceeds could be invested only in specified securities such as a money market fund meeting conditions of the Investment Company Act or in securities that are direct obligations of, or obligations guaranteed as to principal or interest by, the United States. | ||||
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
account and instead to hold the funds in the trust account in cash or in an interest bearing demand deposit account at a bank. | ||||||
Receipt of interest on escrowed funds | Interest on proceeds from the trust account to be paid to shareholders is reduced by (i) taxes payable and (ii) in the event of our liquidation for failure to complete our initial business combination within the allotted time, up to $100,000 of net interest that may be released to us should we have no or insufficient working capital to fund the costs and expenses of our dissolution and liquidation. | Interest on funds in escrow account would be held for the sole benefit of investors, unless and only after the funds held in escrow were released to us in connection with our completion of a business combination. | ||||
Limitation on fair value or net assets of target business | Nasdaq rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of our assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the initial business combination. | The fair value or net assets of a target business must represent at least 80% of the maximum offering proceeds. | ||||
Trading of securities issued | The units are expected to begin trading on or promptly after the date of this prospectus. The Class A ordinary shares and rights comprising the units will begin separate trading on the 52nd day following the date of this prospectus unless Santander US Capital Markets LLC informs us of its decision to allow earlier separate trading, subject to our having filed the Current Report on Form 8-K described below and having issued a press release announcing when such separate trading will begin. We will file the Current Report on Form 8-K promptly after the closing of this offering, which closing is anticipated to take place three business days from the date of this prospectus. If the over-allotment option is exercised following the initial filing of such Current Report on Form 8-K, a second or amended Current Report on Form 8-K will be filed to provide updated information to reflect the exercise of the over-allotment option. | No trading of the units or the underlying Class A ordinary shares and rights would be permitted until the completion of a business combination. During this period, the securities would be held in the escrow or trust account. | ||||
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
Election to remain an investor | We will provide our public shareholders with the opportunity to redeem their public shares, regardless of whether they abstain, vote for, or vote against, our initial business combination, for cash at a per share price equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account (net of taxes payable), divided by the number of then-outstanding public shares, upon the completion of our initial business combination, subject to the limitations and on the conditions described herein. We may not be required by law to hold a shareholder vote. If we are not required by law and do not otherwise decide to hold a shareholder vote, we will, pursuant to our amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC which will contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under the SEC’s proxy rules. If, however, we hold a shareholder vote, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law and our amended and restated memorandum and articles of association, which requires the affirmative vote of at least a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company. However, if our initial business combination is structured as a statutory merger or consolidation with another company under Cayman Islands law, in addition to obtaining approval of our initial business combination by ordinary resolution, the approval of the statutory merger or consolidation will require a special resolution under Cayman Islands law, which requires the affirmative by such shareholders | A prospectus containing information pertaining to the business combination required by the SEC would be sent to each investor. Each investor would be given the opportunity to notify the company in writing, within a period of no less than 20 business days and no more than 45 business days from the effective date of a post-effective amendment to the company’s registration statement, to decide if he, she or it elects to remain a shareholder of the company or require the return of his, her or its investment. If the company has not received the notification by the end of the 45 business day, funds and interest or dividends, if any, held in the trust or escrow account are automatically returned to the shareholder. Unless a sufficient number of investors elect to remain investors, all funds on deposit in the escrow account must be returned to all of the investors and none of the securities are issued. | ||||
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company. Additionally, each public shareholder may elect to redeem their public shares irrespective of whether they vote for or vote against the proposed transaction, or whether they do not vote or abstain from voting on the proposed transaction, or whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction. | ||||||
Business combination deadline | If we have not completed our initial business combination within the completion window, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and less up to $100,000 of interest to pay liquidation and dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. | If an acquisition has not been completed within 18 months after the effective date of the company’s registration statement, funds held in the trust or escrow account are returned to investors. | ||||
Release of funds | Except with respect to taxes payable, none of the funds held in trust will be released from the trust account until the earliest of (i) the completion of our initial business combination, (ii) the redemption of our public shares if we are unable to complete our initial business combination within the completion window, subject to applicable law, or (iii) the redemption of our public shares properly submitted in connection with a shareholder vote to approve an amendment | The proceeds held in the escrow account are not released until the earlier of the completion of a business combination or the failure to effect a business combination within the allotted time. | ||||
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination within the completion window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity. | ||||||
Delivering share certificates in connection with the exercise of redemption rights | We intend to require our public shareholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to, at the holder’s option, either deliver their share certificates to our transfer agent or deliver their shares to our transfer agent electronically using the Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) system, prior to the date set forth in the proxy materials or tender offer documents, as applicable. In the case of proxy materials, this date may be up to two business days prior to the scheduled vote on the proposal to approve the initial business combination. In addition, if we conduct redemptions in connection with a shareholder vote, we intend to require a public shareholder seeking redemption of its public shares to also submit a written request for redemption to our transfer agent two business days prior to the scheduled vote in which the name of the beneficial owner of such shares is included. The proxy materials or tender offer documents, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will indicate whether we are requiring public shareholders to satisfy such delivery requirements. Accordingly, a public shareholder would have up to two business days prior to the scheduled vote on the initial business combination if we distribute proxy materials, or from the time we send out our tender offer materials until the close of the tender offer period, as applicable, to submit or tender its shares if it wishes to seek to exercise its redemption rights. | Many blank check companies provide that a shareholder can vote against a proposed business combination and check a box on the proxy card indicating that such shareholder is seeking to exercise its redemption rights. After the business combination is approved, the company would contact such shareholder to arrange for delivery of its share certificates to verify ownership. | ||||
Limitation on redemption rights | If we seek shareholder approval of our initial business combination and we do not conduct | Many blank check companies provide no restrictions on the ability of shareholders to | ||||
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
of shareholders holding more than 15% of the shares sold in this offering if we hold a shareholder vote | redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to Excess Shares without our prior consent. However, we would not restrict our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. | redeem shares based on the number of shares held by such shareholders in connection with an initial business combination. | ||||
Name | Age | Position | ||||
Boon Sim | 62 | Director, Chief Executive Officer, Chief Financial Officer and Chairman | ||||
John Stein | 60 | Director nominee | ||||
Kevin Costello | 62 | Director nominee | ||||
Karen Richardson | 62 | Director nominee | ||||
• | Repayment of up to an aggregate of $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses; |
• | Payment of consulting, success or finder fees to our independent directors, advisors, or their respective affiliates in connection with the consummation of our initial business combination; |
• | We may engage our sponsor or an affiliate of our sponsor as an advisor or otherwise in connection with our initial business combination and certain other transactions and pay such person or entity a salary or fee in an amount that constitutes a market standard for comparable transactions; |
• | Reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination; and |
• | Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement shares of the post-business combination entity at a price of $10.00 per 1.1 shares at the option of the lender. Such shares would be identical to the private placement shares. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. |
• | assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent registered public accounting firm; the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent registered public accounting firm all relationships the independent registered public accounting firm have with us in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the independent registered public accounting firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating our chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer’s based on such evaluation; |
• | reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive compensation and equity based plans that are subject to board approval of all of our other officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | duty to not improperly fetter the exercise of future discretion; |
• | duty to exercise authority for the purpose for which it is conferred and a duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
Individual | Entity | Entity’s Business | Affiliation | ||||||
Boon Sim | Artius Capital | Investment | Founder and Managing Partner | ||||||
Canada Pension Plan Investment Board | Investment | Director | |||||||
John Stein | Fidelis Capital | Investment | Founding Principal | ||||||
IntraMicron, Inc. | Technology | Chairman of the Board | |||||||
Kevin Costello | Elemica, Inc. | Technology | Director | ||||||
Kahua, Inc. | Technology | Director | |||||||
Unison Software, Inc. | Technology | Director | |||||||
Tribute Technology | Technology | Director | |||||||
NPI, LLC | Technology | Director | |||||||
Karen Richardson | BP plc | Energy | Non-executive Director | ||||||
Exponent, Inc. | Consulting | Lead Independent Director | |||||||
• | Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our initial shareholders purchased founder shares prior to the date of this prospectus and will purchase private placement units in a transaction that will close simultaneously with the closing of this offering. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with the completion of our initial business combination. Additionally, our sponsor, officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination within the prescribed time frame, although they will be entitled to liquidating distributions from assets outside the trust account. If we do not complete our initial business combination within the prescribed time frame, the private placement units will expire worthless. Furthermore, our sponsor, officers and directors have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of our initial business combination; or (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of our Class A ordinary shares equals or exceeds |
• | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. |
• | The personal and financial interests of our directors and executive officers may influence their motivation in timely identifying and pursuing an initial business combination or completing our initial business combination. The different timelines of competing business combinations could cause our directors and executive officers to prioritize a different business combination over finding a suitable acquisition target for our business combination. Consequently, our directors’ and executive officers’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our shareholders’ best interest, which could negatively impact the timing for a business combination. |
• | Upon the closing of this offering and assuming no exercise of the over-allotment option, our sponsor will have invested in us an aggregate of $1,775,000, comprised of the $25,000 purchase price for the founder shares and the $1,750,000 purchase price for the private placement units. Assuming a trading price of $10.00 per public share upon consummation of our initial business combination, the 5,000,000 founder shares (assuming no exercise of the over-allotment option, excluding the 175,000 private placement shares, the distribution of distributable shares and forfeiture of founder shares concurrently therewith, after automatic conversion of the 5,000,000 founder shares) would have an aggregate implied value of $50,000,000. Even if the trading price of our ordinary shares were as low as $0.355 per share, and disregarding the private placement units, the value of the founder shares would be equal to our sponsor’s aggregate initial investment in us. As a result, our sponsor is likely to be able to make a substantial profit on its investment in us at a time when our public shares have lost significant value. Accordingly, members of our management team, who own interests in our sponsor, may be more willing to pursue a business combination with a riskier or less-established target business than would be the case if our sponsor had paid the same per share price for the founder shares as our public shareholders paid for their public shares. In addition, our independent directors who are also non-managing members of our sponsor may have different interests than public shareholders due to their upfront indirect investment in the company. |
• | In the event our sponsor or members of our management team provide loans to us to finance transaction costs and/or incur expenses on our behalf in connection with an initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such loans may not be repaid and/or such expenses may not be reimbursed unless we consummate such business combination. |
• | If we agree to pay our sponsor, officers or directors, or our or their affiliates, a finder’s fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the completion of our initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as any such fee may not be paid unless we consummate such business combination, which, if made prior to the completion of our initial business combination, will be paid from net proceeds of this offering and the sale of the private placement units not held in the trust account. |
• | We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors, or completing the business combination through a joint venture or other form of shared ownership with our sponsor, officers or directors. Accordingly, such affiliated person(s) may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such affiliated person(s) would have interests |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our officers, directors and director nominees; and |
• | all our officers and directors as a group. |
Name and Address of Beneficial Owner(1) | Number of Class A Ordinary Shares Beneficially Owned | Approximate Percentage of Outstanding Class A Ordinary Shares | Number of Class B Ordinary Shares Beneficially Owned | Approximate Percentage of Outstanding Class B Ordinary Shares | ||||||||||||||
Before Offering | After Offering | Before Offering | After Offering | |||||||||||||||
Artius II Acquisition Partners LLC(2)(3) | — | — | * | 5,750,000 | 100% | 100% | ||||||||||||
Boon Sim(4) | — | — | * | 5,750,000 | 100% | 100% | ||||||||||||
John Stein | — | — | — | — | — | — | ||||||||||||
Kevin Costello | — | — | — | — | — | — | ||||||||||||
Karen Richardson | — | — | — | — | — | — | ||||||||||||
All officers, directors and director nominees as a group (4 persons) | — | — | * | 5,750,000 | 100% | 100% | ||||||||||||
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of the following is c/o Artius II Acquisition Inc., 3 Columbus Circle, Suite 1609, New York, NY 10019. |
(2) | Interests shown consist of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares in connection with the consummation of our initial business combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment, as described in the section entitled “Description of Securities” After Offering interests take into account both founder shares and 175,000 private placement shares, classified as Class A ordinary shares, underlying the private placement units. |
(3) | Includes up to 750,000 founder shares that will be surrendered for no consideration depending on the extent to which the underwriter’s over-allotment option is exercised. |
(4) | Mr. Sim is the sole managing member of Artius II Acquisition Partners LLC and exercises voting and investment power with respect to the Class B ordinary shares held by Artius II Acquisition Partners LLC. The shares beneficially owned by Artius II Acquisition Partners LLC may also be deemed to be beneficially owned by Mr. Sim. |
• | Repayment of up to an aggregate of $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses; |
• | Payment of consulting, success or finder fees to our independent directors, advisors, or their respective affiliates in connection with the consummation of our initial business combination; |
• | We may engage our sponsor or an affiliate of our sponsor as an advisor or otherwise in connection with our initial business combination and certain other transactions and pay such person or entity a salary or fee in an amount that constitutes a market standard for comparable transactions; |
• | Reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination; and |
• | Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement shares of the post-business combination entity at a price of $10.00 per 1.1 shares at the option of the lender. Such shares would be identical to the private placement shares. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. |
• | 20,000,000 Class A ordinary shares underlying public units issued as part of this offering; |
• | 175,000 Class A ordinary shares underlying private placement units issued as part of this offering; and |
• | 5,000,000 Class B ordinary shares held by our initial shareholders. |
• | the names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member and the voting rights of the shares of each member; |
• | whether voting rights attach to the shares in issue; |
• | the date on which the name of any person was entered on the register as a member; and |
• | the date on which any person ceased to be a member. |
• | we are not proposing to act illegally or beyond the scope of our corporate authority and the statutory provisions as to majority vote have been complied with; |
• | the shareholders have been fairly represented at the meeting in question; |
• | the arrangement is such as a businessman would reasonably approve; and |
• | the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount to a “fraud on the minority.” |
• | a company is acting, or proposing to act, illegally or beyond the scope of its authority; |
• | the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of votes which have actually been obtained; or |
• | those who control the company are perpetrating a “fraud on the minority.” |
• | an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies; |
• | an exempted company’s register of members is not open to inspection and can be kept outside of the Cayman Islands; |
• | an exempted company does not have to hold an annual general meeting; |
• | an exempted company may issue shares with no nominal or par value; |
• | an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 30 years in the first instance); and |
• | an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
• | If we have not completed our initial business combination within the completion window, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable and less up to $100,000 of interest to pay liquidation and dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), |
• | Prior to our initial business combination, we may not, except in connection with the conversion of Class B ordinary shares into Class A ordinary shares where the holders of such shares have waived any rights to receive funds from the trust account, issue additional shares that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote as a class with public shares on any initial business combination; |
• | If a shareholder vote on our initial business combination is not required by law and we do not decide to hold a shareholder vote for business or other reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act; |
• | Nasdaq rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account); |
• | If our shareholders approve an amendment to our amended and restated memorandum and articles of association not for the purposes of approving, or in conjunction with the consummation of, an initial business combination (i) to modify the substance or timing of our obligation to allow redemption in connection with an initial business combination or to redeem 100% of our public shares if we do not complete an initial business combination within the completion window or (ii) with respect to any other provision relating to the rights of holders of our Class A ordinary shares or pre-initial business combination activity, we will provide our public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (which interest shall be net of taxes payable), divided by the number of then-outstanding public shares; |
• | We will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations; and |
• | Only holders of our Class B ordinary shares have the right to vote on appointing or removing directors or continuing our company in a jurisdiction outside the Cayman Islands (as further described herein), prior to the consummation of our initial business combination. |
• | where this is necessary for the performance of our rights and obligations under any purchase agreements; |
• | where this is necessary for compliance with a legal and regulatory obligation to which we are subject (such as compliance with anti-money laundering, counter terrorist financing, prevention of proliferation financing, financial sanctions and FATCA/CRS requirements); and/or |
• | where this is necessary for the purposes of our legitimate interests and such interests are not overridden by your interests, fundamental rights or freedoms. |
• | be informed about the purposes for which your personal data are processed; |
• | access your personal data; |
• | stop direct marketing; |
• | restrict the processing of your personal data; |
• | have incomplete or inaccurate personal data corrected; |
• | ask us to stop processing your personal data; |
• | be informed of a personal data breach (unless the breach is unlikely to be prejudicial to you); |
• | complain to the Data Protection Ombudsman; and |
• | require us to delete your personal data in some limited circumstances. |
• | 1% of the total number of Class A ordinary shares then outstanding, which will equal 201,750 shares immediately after this offering (or 231,750 if the underwriter exercises in full their over-allotment option); or |
• | the average weekly reported trading volume of the Class A ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
1. | That no law which is hereafter enacted in the Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to the Company or its operations; and |
2. | In addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable: |
2.1 | On or in respect of the shares, debentures or other obligations of the Company; or |
2.2 | by way of the withholding in whole or in part of any relevant payment as defined in the Tax Concessions Act (As Revised). |
• | banks, financial institutions or financial services entities; |
• | broker-dealers; |
• | taxpayers that are subject to the mark-to-market tax accounting rules; |
• | tax-exempt entities; |
• | governments or agencies or instrumentalities thereof; |
• | insurance companies; |
• | regulated investment companies; |
• | real estate investment trusts; |
• | expatriates or former long-term residents of the United States; |
• | nonresident alien individuals present in the United States for a period or periods aggregating 183 days or more during the taxable year; |
• | persons that actually or constructively own ten percent or more (by vote or value) of our shares; |
• | persons that acquired our securities pursuant to an exercise of employee share options, in connection with employee share incentive plans or otherwise as compensation or in connection with the performance of services; |
• | persons that hold our securities as part of a straddle, constructive sale, hedge, wash sale, conversion or other integrated or similar transaction; |
• | entities or arrangements classified as partnerships for U.S. federal income tax purposes) and any beneficial owners of such partnerships; and |
• | U.S. Holders (as defined below) whose functional currency is not the U.S. dollar. |
• | the U.S. Holder’s gain or excess distribution will be allocated ratably over the U.S. Holder’s holding period for the Class A ordinary shares or rights; |
• | the amount allocated to the U.S. Holder’s taxable year in which the U.S. Holder recognized the gain or received the excess distribution, or to the portion of the U.S. Holder’s holding period before the first day of our first taxable year in which we are a PFIC, will be taxed as ordinary income; |
• | the amount allocated to each other taxable year (or portion thereof) of the U.S. Holder and included in its holding period will be taxed at the highest tax rate in effect for that year and applicable to the U.S. Holder without regard to the U.S. Holder’s other items of income and loss for that year; and |
• | an additional amount equal to the interest charge generally applicable to underpayments of tax will be imposed on the U.S. Holder with respect to the tax attributable to each such other taxable year of the U.S. Holder. |
(i) | we were classified as a PFIC at any time during such U.S. Holder’s holding period in our Class A ordinary shares or rights, and |
(ii) | the U.S. Holder had not timely made (a) a QEF election for the first taxable year in which the U.S. Holder owned such Class A ordinary shares or in which we were a PFIC, whichever is later (or a QEF election along with a purging election), or (b) a mark-to-market election with respect to such Class A ordinary shares. Generally, as discussed above, we expect that neither election would apply to the rights. |
Underwriter | Number of Units | ||
Santander US Capital Markets LLC | 20,000,000 | ||
Total | 20,000,000 | ||
Per Unit | Total | |||||||||||
Without Over- allotment | With Over- allotment | Without Over- allotment | With Over- allotment | |||||||||
Underwriting Discounts and Commissions paid by us(1) | $0.3125 | $0.3109 | $6,250,000 | $7,150,000 | ||||||||
(1) | Includes $250,000 (such amount to remain unchanged in the event to underwriter’s over-allotment option is exercised in full) shall be payable to the underwriter upon the closing of this offering. Also includes $0.30 per unit on all units sold ($6,000,000 in the aggregate or up to $6,900,000 in the aggregate if the underwriter’s over-allotment option is exercised in full ) payable to the underwriter for deferred underwriting commissions to be deposited into a trust account located in the United States and released to Santander US Capital Markets LLC for its own account only upon the completion of an initial business combination. Such deferred underwriting commissions will not be payable with respect to any shares redeemed in connection with an initial business combination, and may be paid at the sole and absolute discretion of our management team to any one or more FINRA members, which may or may not include the underwriter. |
• | Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. |
• | Over-allotment involves sales by the underwriter of units in excess of the number of units the underwriter is obligated to purchase, which creates a syndicate short position. The short position may be either a |
• | Syndicate covering transactions involve purchases of the units in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of units to close out the short position, the underwriter will consider, among other things, the price of units available for purchase in the open market as compared to the price at which they may purchase units through the over-allotment option. If the underwriter sell more units than could be covered by the over-allotment option, a naked short position, the position can only be closed out by buying units in the open market. A naked short position is more likely to be created if the underwriter is concerned that there could be downward pressure on the price of the units in the open market after pricing that could adversely affect investors who purchase in this offering. |
• | Penalty bids permit the representative to reclaim a selling concession from a syndicate member when the units originally sold by the syndicate member are purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions. |
(a) | to any legal entity which is a qualified investor as defined under the Prospectus Regulation; |
(b) | to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the underwriter for any such offer; or |
(c) | in any other circumstances falling within Article 1(4) of the Prospectus Regulation, provided that no such offer of units shall require the Issuer or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. |
(a) | to any legal entity which is a qualified investor as defined in Article 2 of the U.K. Prospectus Regulation; |
(b) | to fewer than 150 natural or legal persons (other than qualified investors as defined in Article 2 of the U.K. Prospectus Regulation), subject to obtaining the prior consent of the Representative for any such offer; or |
(c) | in any other circumstances falling within section 86 of the Financial Services and Markets Act 2000, as amended (the “FSMA”), provided that no such offer of units shall require the Issuer or any Manager to publish a prospectus pursuant to section 85 of the FSMA or supplement a prospectus pursuant to Article 23 of the U.K. Prospectus Regulation. |
• | the purchaser is entitled under applicable provincial securities laws to purchase the units without the benefit of a prospectus qualified under those securities laws as it is an “accredited investor” as defined under National Instrument 45 - 106 - Prospectus Exemptions or Section 73.3 of the Securities Act (Ontario), as applicable; |
• | the purchaser is a “permitted client” as defined in National Instrument 31 - 103 - Registration Requirements, Exemptions and Ongoing Registrant Obligations; |
• | where required by law, the purchaser is purchasing as principal and not as agent; and |
• | the purchaser has reviewed the text above under Resale Restrictions. |
Assets: | |||
Deferred offering costs | $503,670 | ||
Total Assets | $503,670 | ||
Liabilities and Shareholder’s Equity: | |||
Accrued expenses | $34,975 | ||
Accrued offering costs | 401,354 | ||
Promissory note – related party | 127,615 | ||
Total Current Liabilities | 563,944 | ||
Commitments and Contingencies (Note 6) | |||
Shareholder’s Deficit | |||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | — | ||
Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized; none issued or outstanding | — | ||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding(1)(2) | 575 | ||
Additional paid-in capital | 24,425 | ||
Accumulated deficit | (85,274) | ||
Total Shareholder’s Deficit | (60,274) | ||
Total Liabilities and Shareholder’s Deficit | $503,670 | ||
(1) | Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (Note 7). |
(2) | In October 2024, the Sponsor forfeited an aggregate of 1,437,500 founder shares for no consideration, such that the Sponsor owns an aggregate of 5,750,000 founder shares. All share and per share data has been retrospectively presented. |
General and administrative costs | $85,274 | ||
Net loss | $(85,274) | ||
Basic and diluted weighted average Class B ordinary shares outstanding(1)(2) | 5,000,000 | ||
Basic and diluted net loss per Class B ordinary share | $(0.02) | ||
(1) | Excludes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (Note 7). |
(2) | In October 2024, the Sponsor forfeited an aggregate of 1,437,500 founder shares for no consideration, such that the Sponsor owns an aggregate of 5,750,000 founder shares. All share and per share data has been retrospectively presented. |
Class B Ordinary shares | Additional Paid-In Capital | Accumulated Deficit | Shareholder’s Deficit | ||||||||||||
Shares | Amount | ||||||||||||||
Balance as of July 25, 2024 (inception) | — | $— | $— | $— | $— | ||||||||||
Class B ordinary shares issued to Sponsor(1)(2) | 5,750,000 | 575 | 24,425 | — | 25,000 | ||||||||||
Net loss | — | — | — | (85,274) | (85,274) | ||||||||||
Balance as of December 31, 2024 | 5,750,000 | $575 | $24,425 | $(85,274) | $(60,274) | ||||||||||
(1) | Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (Note 7). |
(2) | In October 2024, the Sponsor forfeited an aggregate of 1,437,500 founder shares for no consideration, such that the Sponsor owns an aggregate of 5,750,000 founder shares. All share and per share data has been retrospectively presented. |
Cash flows from operating activities: | |||
Net loss | $(85,274) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | |||
General and administrative costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 11,804 | ||
Payment of expenses through promissory note-related party | 38,495 | ||
Changes in operating assets and liabilities: | |||
Accrued expenses | 34,975 | ||
Net cash used in operating activities | — | ||
Net change in cash | — | ||
Cash, beginning of the period | — | ||
Cash, end of the period | $— | ||
Supplemental disclosure of cash flow information: | |||
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $13,196 | ||
Deferred offering costs paid through promissory note – related party | $89,120 | ||
Deferred offering costs included in accrued offering costs | $401,354 | ||
Item 13. | Other Expenses of Issuance and Distribution. |
Legal fees and expenses | $400,000 | ||
Printing and engraving expenses | 35,000 | ||
Trustee fees and expenses | 8,000 | ||
Accounting fees and expenses | 75,000 | ||
SEC/FINRA expenses | 90,000 | ||
Travel and road show expenses | 5,000 | ||
Nasdaq listing fees | 85,000 | ||
Miscellaneous | 52,000 | ||
Total | $750,000 | ||
Item 14. | Indemnification of Directors and Officers. |
Item 15. | Recent Sales of Unregistered Securities. |
Item 16. | Exhibits and Financial Statement Schedules. |
Exhibit No. | Description | ||
Form of Underwriting Agreement. | |||
Memorandum and Articles of Association. | |||
Form of Amended and Restated Memorandum and Articles of Association. | |||
Specimen Unit Certificate. | |||
Specimen Ordinary Share Certificate. | |||
Specimen Right Certificate. | |||
Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant. | |||
Form of Contingent Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant. | |||
Opinion of Cleary Gottlieb Steen & Hamilton LLP. | |||
Opinion of Maples and Calder (Cayman) LLP, Cayman Islands counsel to the Registrant. | |||
Form of Letter Agreement among the Registrant, Artius II Acquisition Partners LLC and each of the officers and directors of the Registrant. | |||
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant. | |||
Form of Registration Rights Agreement among the Registrant, Artius II Acquisition Partners LLC and the Holders signatory thereto. | |||
Form of Private Placement Units Purchase Agreement between the Registrant and Artius II Acquisition Partners LLC. | |||
Form of Indemnity Agreement. | |||
Promissory Note issued to Artius II Acquisition Partners LLC. | |||
Securities Subscription Agreement between Artius II Acquisition Partners LLC and the Registrant. | |||
Amendment No. 1 to Securities Subscription Agreement between Artius II Acquisition Partners LLC and the Registrant. | |||
Form of Administrative Services Agreement between the Registrant and Artius Management LLC. | |||
Form of Advisory Services Agreement. | |||
Form of Code of Ethics. | |||
Consent of Withum Smith+Brown, PC. | |||
Consent of Cleary Gottlieb Steen & Hamilton LLP (included on Exhibit 5.1). | |||
Consent of Maples and Calder (Cayman) LLP (included on Exhibit 5.2). | |||
Power of Attorney (included on the signature page of the initial filing). | |||
Audit Committee Charter. | |||
Compensation Committee Charter. | |||
Consent of Karen Richardson to be named as director nominee. | |||
Consent of Kevin Costello to be named as director nominee. | |||
Consent of John Stein to be named as director nominee. | |||
Filing Fee Table. | |||
* | Previously filed. |
Item 17. | Undertakings. |
(a) | The undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser. |
(b) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
(c) | The undersigned registrant hereby undertakes that: |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
• | to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
• | to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
• | to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
(2) | For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | For the purpose of determining liability under the Securities Act of 1933 of any purchaser, if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(5) | For the purpose of determining liability of a registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a |
(i) | any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by an undersigned registrant; |
(iii) | the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
Artius II Acquisition Inc. | ||||||
By: | /s/ Boon Sim | |||||
Name: | Boon Sim | |||||
Title: | Chief Executive Officer, Chief Financial Officer and Chairman | |||||
Name | Position | Date | ||||||||
/s/ Boon Sim | Chief Executive Officer and Chairman (principal executive officer) | February 7, 2025 | ||||||||
Boon Sim | ||||||||||
/s/ Boon Sim | Chief Financial Officer (principal financial and accounting officer) | February 7, 2025 | ||||||||
Boon Sim | ||||||||||
By: | /s/ Boon Sim | |||||
Name: | Boon Sim | |||||
Title: | Chief Executive Officer, Chief Financial Officer and Chairman | |||||